Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy WCC Tan, SN Nerurkar, HY Cai, HHM Ng, D Wu, YTF Wee, JCT Lim, ... Cancer Communications 40 (4), 135-153, 2020 | 457 | 2020 |
Corneal cross-linking: the evolution of treatment for corneal diseases D Wu, DKA Lim, BXH Lim, N Wong, F Hafezi, R Manotosh, CHL Lim Frontiers in Pharmacology 12, 686630, 2021 | 34 | 2021 |
Comparison between UMAP and t-SNE for multiplex-immunofluorescence derived single-cell data from tissue sections D Wu, JY Poh Sheng, GT Su-En, M Chevrier, JL Jie Hua, TL Kiat Hon, ... BioRxiv, 549659, 2019 | 21 | 2019 |
Dupilumab-associated ocular manifestations: a review of clinical presentations and management D Wu, BS Daniel, AJX Lai, N Wong, DKA Lim, DF Murrell, BXH Lim, ... Survey of ophthalmology 67 (5), 1419-1442, 2022 | 18 | 2022 |
Impact of microplastics on the ocular surface D Wu, BXH Lim, I Seah, S Xie, JE Jaeger, RK Symons, AL Heffernan, ... International Journal of Molecular Sciences 24 (4), 3928, 2023 | 9 | 2023 |
Comparison of the safety and efficacy between minimally invasive cardiac surgery and median sternotomy in a low-risk mixed Asian population in Singapore ZX Ong, D Wu, H Luo, G Chang, F Sazzad, JA Sule, P Hu, T Kofidis Singapore medical journal 63 (11), 641-648, 2022 | 4 | 2022 |
Novel therapeutics for dry eye disease D Wu, L Tong, A Prasath, BXH Lim, DKA Lim, CHL Lim Annals of Medicine 55 (1), 1211-1212, 2023 | 2 | 2023 |
Management of corneal neovascularization: Current and emerging therapeutic approaches D Wu, KE Chan, BXH Lim, DKA Lim, WM Wong, C Chai, R Manotosh, ... Indian Journal of Ophthalmology 72 (Suppl 3), S354-S371, 2024 | 1 | 2024 |
Retinal vein occlusion following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccination D Wu, BXH Lim, DKA Lim, G Lingam, CHL Lim Singapore Medical Journal, 10.4103, 2023 | 1 | 2023 |
Profiles of women presenting for abortions in Singapore at the National University Hospital: focus on married women XWG Pek, WS Teoh, D Wu, K Singh Singapore medical journal 64 (5), 302-306, 2023 | 1 | 2023 |
A proposed management algorithm for dupilumab-associated ocular side effects: a collaborative effort between dermatologists and ophthalmologists D Wu, BS Daniel, AJX Lai, N Wong, DKA Lim, DF Murrell, BXH Lim, ... Journal of the European Academy of Dermatology and Venereology: JEADV, 2022 | 1 | 2022 |
Automated suture fastener gaining complete commitment: cumulative propensity-matched comparison with hand-tied knot in heart valve surgery A Ler, D Wu, OZ Xian, F Sazzad, KG Swee, T Kofidis Innovations 16 (4), 334-342, 2021 | 1 | 2021 |
Minimally Invasive Coronary Artery Bypass Grafting in a Low-Risk Asian Cohort: A Propensity-Score Matched Study ZX Ong, D Wu, JA Sule, G Chang, F Sazzad, H Luo, P Hu, T Kofidis Brazilian Journal of Cardiovascular Surgery 39 (4), 2024 | | 2024 |
Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients? F Sazzad, HD Luo, G Chang, D Wu, ZX Ong, T Kofidis, GS Kang Journal of Cardiothoracic Surgery 19 (1), 363, 2024 | | 2024 |
Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity F Sazzad, HD Luo, G Chang, D Wu, ZX Ong, T Kofidis, GS Kang | | 2024 |
Microplastics Identified in Commercial Over-the-counter Lubricant Eyedrops JE Jaeger, M Burke, D Wu, EEM Curren, SCY Leong, R Symons, BXH Lim, ... medRxiv, 2024.05. 26.24307941, 2024 | | 2024 |
Minimally symptomatic facial laser-induced retinal burn D Wu, TYT Shen, BXH Lim, DKA Lim, CHL Lim Canadian Journal of Emergency Medicine 23 (5), 726-727, 2021 | | 2021 |
Minimally-invasive coronary artery bypass grafting offers superior outcomes compared to conventional median sternotomy: a propensity-score matched study D Wu, ZX Ong, H Luo, G Chang, F Sazzad, J Sule, P Hu, T Kofidis | | 2021 |
Harmony: Integrative tool to analyse and visualise multiplex-immunofluorescence single-cell data D Wu, J Yeong, G Tan, M Chevrier, J Loh, T Lim, J Chen JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |